We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+1.17%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$47.1B
AUM Growth
-$899M
(-1.9%)
Cap. Flow
-$982M
Cap. Flow
% of AUM
-2.08%
Top 10 Holdings %
Top 10 Hldgs %
35.43%
Holding
967
New
122
Increased
219
Reduced
464
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$250M |
| 2 |
Starbucks
SBUX
|
+$152M |
| 3 |
CERN
Cerner Corp
CERN
|
+$122M |
| 4 |
Colgate-Palmolive
CL
|
+$87.1M |
| 5 |
Procter & Gamble
PG
|
+$77.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$456M |
| 2 |
Cisco
CSCO
|
+$392M |
| 3 |
Analog Devices
ADI
|
+$151M |
| 4 |
United Parcel Service
UPS
|
+$148M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$89.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.05% |
| 2 | Consumer Discretionary | 15.92% |
| 3 | Financials | 12.69% |
| 4 | Healthcare | 12.47% |
| 5 | Communication Services | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
PennyMac Financial
PFSI
$4.02B
| $34K | ﹤0.01% |
1,522
+852
| +127% | +$19.8K |
|
627
Quad
QUAD
$525M
| $34K | ﹤0.01% |
1,344
-217
| -14% | -$5.28K |
|
628
Sanmina
SANM
$10.9B
| $34K | ﹤0.01% |
1,287
+156
| +14% | +$4.46K |
|
|
TSE
629
DELISTED
Trinseo
TSE
| $34K | ﹤0.01% |
461
+339
| +278% | +$26.7K |
|
630
Wabash National
WNC
$527M
| $34K | ﹤0.01% |
1,621
-149
| -8% | -$3.36K |
|
|
XHR
631
Xenia Hotels & Resorts
XHR
$1.79B
| $34K | ﹤0.01% |
1,699
+1,326
| +355% | +$27.5K |
|
|
SYKE
632
DELISTED
SYKES Enterprises Inc
SYKE
| $34K | ﹤0.01% |
1,163
| – | – |
|
|
HZNP
633
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $34K | ﹤0.01% |
+2,389
| New | +$35.3K |
|
|
SYNT
634
DELISTED
Syntel Inc
SYNT
| $34K | ﹤0.01% |
+1,327
| New | +$32.9K |
|
|
FBC
635
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $34K | ﹤0.01% |
965
| – | – |
|
636
Peabody Energy
BTU
$2.9B
| $33K | ﹤0.01% |
895
-183
| -17% | -$7.28K |
|
637
Cirrus Logic
CRUS
$6.26B
| $33K | ﹤0.01% |
817
+104
| +15% | +$4.83K |
|
638
Molina Healthcare
MOH
$10.3B
| $33K | ﹤0.01% |
412
-62
| -13% | -$4.99K |
|
639
TTM Technologies
TTMI
$14.5B
| $33K | ﹤0.01% |
2,171
| – | – |
|
|
UMH
640
UMH Properties
UMH
$1.36B
| $33K | ﹤0.01% |
+2,474
| New | +$32.2K |
|
|
TBRG
641
DELISTED
TruBridge
TBRG
| $33K | ﹤0.01% |
1,136
-16
| -1% | -$479 |
|
|
AAIC
642
DELISTED
Arlington Asset Investment Corp.
AAIC
| $33K | ﹤0.01% |
+3,014
| New | +$34.1K |
|
|
EXTN
643
DELISTED
Exterran Corporation
EXTN
| $33K | ﹤0.01% |
1,248
+765
| +158% | +$22.1K |
|
|
BGG
644
DELISTED
Briggs & Stratton Corp.
BGG
| $33K | ﹤0.01% |
1,530
+159
| +12% | +$3.71K |
|
|
AVX
645
DELISTED
AVX Corporation
AVX
| $33K | ﹤0.01% |
1,983
+101
| +5% | +$1.78K |
|
|
IPHS
646
DELISTED
Innophos Holdings, Inc.
IPHS
| $33K | ﹤0.01% |
812
+54
| +7% | +$2.37K |
|
647
Atkore
ATKR
$3.16B
| $32K | ﹤0.01% |
1,634
+1,247
| +322% | +$26.8K |
|
648
FMC
FMC
$1.33B
| $32K | ﹤0.01% |
477
-1,096
| -70% | -$81.7K |
|
649
Photronics
PLAB
$1.93B
| $32K | ﹤0.01% |
3,867
+318
| +9% | +$2.66K |
|
650
T. Rowe Price
TROW
$24.3B
| $32K | ﹤0.01% |
300
-553
| -65% | -$61.6K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2018 Portfolio in Review
As of Q1 2018, Loomis, Sayles & Company held 967 positions worth $47.1B, down 1.9% from $48B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Loomis, Sayles & Company's Q1 2018 filing shows 122 new, 219 increased, 464 reduced and 97 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M. The largest sale was Amazon, an estimated $456M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- Loomis, Sayles & Company's largest Q1 2018 buy was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q1 2018, an estimated $250M increase.
- Loomis, Sayles & Company's biggest Q1 2018 reduction was Amazon, cutting an estimated $456M.
- Loomis, Sayles & Company fully exited Analog Devices in Q1 2018, selling an estimated $151M.
- Loomis, Sayles & Company's ten largest holdings make up 35% of its $47.1B portfolio in Q1 2018.
- Loomis, Sayles & Company opened 122 new positions and closed 97 in Q1 2018.
- Loomis, Sayles & Company's portfolio value fell 1.9% quarter-over-quarter to $47.1B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2018, filed 11 May 2018.